Eribulin Mesylate
NDC 43598-125, Eribulin Mesylate, injection, from Dr. Reddys Laboratories Inc.
- Product NDC
- 43598-125
- Status
- Listed
- Labeler
- Dr. Reddys Laboratories Inc
- Dosage form
- INJECTION
- Route
- INTRAVENOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA217473
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/43598-125 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- ERIBULIN MESYLATE.5 mg/mL
Pharmacologic classes
Microtubule Inhibition [PE]; Microtubule Inhibitor [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 43598-125-11 | 43598012511 | 1 VIAL, SINGLE-DOSE in 1 CARTON (43598-125-11) / 2 mL in 1 VIAL, SINGLE-DOSE |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/1038e984-3bf7-5bbf-f1ec-ce15ae330efcMedicare Part B payment limits (ASP)
GET /v1/drugs/asp?ndc=43598-125
Use it
Look up 43598-125 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/43598-125 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 43598-125. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.